ThinkSabio

$CRDF

$0.88▲ +10.0% YTD

5 SEC 13D/G filings tracked · Last updated Oct 27, 2026

Filing History
News
CRDF ▲ +10.0% - Cardiff Oncology, Inc.
CP $0.88▲ +10.0%Oct 27, 2026 · ThinkSabio Blog

$CRDF - Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer…

News
CRDF ▲ +5.3% - Cardiff Oncology, Inc.
CP $0.99▲ +5.3%Oct 21, 2026 · ThinkSabio Blog

$CRDF - Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia…

News
CRDF ▼ -4.1% - Cardiff Oncology, Inc.
CP $1.16▲ -4.1%Sep 14, 2026 · ThinkSabio Blog

$CRDF - Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement…

News
CRDF ▼ -3.9% - Cardiff Oncology, Inc.
CP $0.99▲ -3.9%Sep 2, 2026 · ThinkSabio Blog

$CRDF - Cardiff Oncology to Participate in September 2026 Conferences…

SEC 13D/G
$CRDF SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks Simplified
$0.85▼ -68.16%Jul 27, 2026 · ThinkSabio Blog

$CRDF SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CRDF : $0.85 Sector: Healthcare | YTD: 🔽 -68.16% The SEC disclo…